Clinical Trial Update: Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating apatinib plus camrelizumab in previously treated advanced biliary tract cancer shows completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Phase 2 | Status: COMPLETED